Kaveh Hajifathalian
Appearances
- DateMay 7, 2023Background: Nonalcoholic steatohepatitis (NASH) is a major cause of liver-related morbidity, mortality, and the leading indication for liver transplant in the US. Fibrosis is the best predictor of clinical outcomes in NASH…
Speakers
Weill Cornell Medical CenterWell Cornell Medical CollegeWeill Cornell Medical CollegePresenter
Weill Cornell Medical Center - DateMay 8, 2023Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
Speakers
Weill Cornell Medical CollegeWeill Cornell Medical CenterPresenter
Weill Cornell Medical Center - DateMay 7, 2023Surgical resection is a standard treatment option for management of pancreatic cysts…
Speakers
Rutgers The State University of New JerseyPresenter
- DateMay 6, 2023Colonoscopy withdrawal time (CWT) of at least 6-9 minutes is the minimum time needed for adequate adenoma detection in the general population. The ideal CWT in patients with inflammatory bowel disease (IBD) has not been determined…
Presenter
- DateMay 21, 2024BACKGROUND: Although metabolic dysfunction-associated steatotic liver disease (MASLD) and viral hepatitis are both important etiologies of liver fibrosis, the interaction between the pathologies remains unclear…
Presenter
Speakers
Rutgers The State University of New Jersey
